Domov › Nemalicelični pljučni rak › Illinois › Cicero
Klinične študije za Nemalicelični pljučni rak v Cicero, IL
24 študij za Nemalicelični pljučni rak išče udeležence na lokacijah v Cicero in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Vključevanje udeležencevFaza 1/2
- Hope And Healing Cancer Services /ID# 276223, Hinsdale · 10 mi stran
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Vključevanje udeležencevFaza 3
- Edward Hines Jr VA Hospital, Hines · 4 mi stran
- Advocate Christ Medical Center, Oak Lawn · 9 mi stran
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Vključevanje udeležencevFaza 3
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi stran
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Hope and Healing Cancer Services, Hinsdale · 10 mi stran
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Vključevanje udeležencevFaza 3
- Advocate Christ Medical Center, Oak Lawn · 9 mi stran
- Hope and Healing Cancer Services, Hinsdale · 10 mi stran
- Endeavor Health, Elmhurst · 10 mi stran
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Vključevanje udeležencevFaza 2
- Hope and Healing Clinical Research, Hinsdale · 10 mi stran
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Vključevanje udeležencevFaza 3
- Research Site, Hinsdale · 10 mi stran
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Vključevanje udeležencevFaza 3
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mi stran
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Vključevanje udeležencevFaza 3
- Research Site, Hinsdale · 10 mi stran
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Vključevanje udeležencevFaza 2/3
- Loyola University Medical Center, Maywood · 5 mi stran
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Hope and Healing Cancer Services, Hinsdale · 10 mi stran
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mi stran
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Vključevanje udeležencevFaza 3
- Research Site, Hinsdale · 10 mi stran
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Research Site, Hinsdale · 10 mi stran
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi stran
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Vključevanje udeležencevFaza 3
- Elmhurst Hospital Nancy Knowles Cancer Center, Elmhurst · 10 mi stran
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Vključevanje udeležencevFaza 2
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · 3 mi stran
- Edward Hines Jr VA Hospital, Hines · 4 mi stran
- Loyola University Medical Center, Maywood · 5 mi stran
- in še 2
MYLUNG Consortium Part 3: Observational Study
Vključevanje udeležencevOpazovalna študija
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mi stran
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Vključevanje udeležencevFaza 2
- Edward Hines Jr VA Hospital, Hines · 4 mi stran
- Loyola University Medical Center, Maywood · 5 mi stran
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi stran
- in še 3
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Vključevanje udeležencevFaza 2/3
- Loyola University Medical Center, Maywood · 5 mi stran
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi stran
- Advocate Christ Medical Center, Oak Lawn · 9 mi stran
- in še 2
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Vključevanje udeležencevFaza 2
- Edward Hines Jr VA Hospital, Hines · 4 mi stran
- Loyola University Medical Center, Maywood · 5 mi stran
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi stran
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Vključevanje udeležencevOpazovalna študija
- Advocate Christ Medical Center, Oak Lawn · 9 mi stran
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · 9 mi stran
- Advocate High Tech Medical Park, Palos Heights · 12 mi stran
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Vključevanje udeležencev
- Edward Hines Jr. VA Hospital, Hines, IL, Hines · 4 mi stran
GEMINI-NSCLC: NSCLC Biomarker Study
Vključevanje udeležencevOpazovalna študija
- Hope and Healing Cancer Services, Hinsdale · 10 mi stran
Študije za Nemalicelični pljučni rak v drugih mestih
- Houston, TX145 študij
- New York City, NY121 študij
- Arlington, VA104 študij
- Nashville, TN97 študij
- Boston, MA90 študij
- Los Angeles, CA87 študij
- St. Louis, MO73 študij
- Chicago, IL61 študij
- Baltimore, MD60 študij
- San Antonio, TX59 študij
- Columbus, OH57 študij
- Washington, DC55 študij
Druge študije v Cicero
- Rak pljuč17 študij
- Rak prostate14 študij
- Rak (vse vrste)13 študij
- Rak dojke11 študij
- Akutna mieločna levkemija11 študij
- Kolorektalni rak10 študij
- Rak mehurja8 študij
- Melanom7 študij
- Srčno-žilne bolezni7 študij
- Metastatski rak7 študij
- Množni mielom6 študij
- Burkittov limfom6 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.